DBV Technologies SA
(FRA:DBV)
€
0.65
0.04 (6.56%)
Market Cap: 64.46 Mil
Enterprise Value: 28.17 Mil
PE Ratio: 0
PB Ratio: 1.32
GF Score: 36/100 DBV Technologies SA at SVB Leerink Global Healthcare Conference (Virtual) Transcript
Feb 24, 2021 / 01:00PM GMT
Release Date Price:
€9
(+1.52%)
Joseph Patrick Schwartz
SVB Leerink LLC, Research Division - MD of Rare Diseases & Senior Research Analyst
Hello, everyone. I'm Joe Schwartz at SVB Leerink. It's my pleasure to welcome Daniel Tassé, Chief Executive Officer at DBV Technologies for an update with us today.
Welcome, Daniel. Thanks for joining us.
Daniel TassÃ;DBV Technologies S.A.;CEO;Director
©,-&
Well, thanks for having me, and good morning to you Joe, and to everyone on the web joining us today.
Joseph Patrick Schwartz
SVB Leerink LLC, Research Division - MD of Rare Diseases & Senior Research Analyst
Great. So maybe you can start us off with a quick update and remind us of the recent progress you've been making advancing Viaskin Peanut to market and review for us your goals through the coming year and the catalyst that investors can look forward to.
Daniel TassÃ;DBV Technologies S.A.;CEO;Director
©,-&
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot